CPPG (Synonyms: α-Cyclopropyl-4-phosphonophenylglycine) |
| カタログ番号GC12100 |
CPPG ((RS)-CPPG) は強力なグループ II/III mGlu 受容体アンタゴニストです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 183364-82-1
Sample solution is provided at 25 µL, 10mM.
評判の良い論文で引用されたGlpBio製品
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 183364-82-1 | SDF | |
| 同義語 | α-Cyclopropyl-4-phosphonophenylglycine | ||
| Chemical Name | (R)-2-amino-2-cyclopropyl-2-(4-phosphonophenyl)acetic acid | ||
| Canonical SMILES | OC([C@@](C1CC1)(C(C=C2)=CC=C2P(O)(O)=O)N)=O | ||
| Formula | C11H14NO5P | M.Wt | 271.21 |
| 溶解度 | 1 M sodium hydroxide: soluble | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.6872 mL | 18.4359 mL | 36.8718 mL |
| 5 mM | 0.7374 mL | 3.6872 mL | 7.3744 mL |
| 10 mM | 0.3687 mL | 1.8436 mL | 3.6872 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC42417 4-hydroxy-3-Methoxyphenylglycol (piperazine salt)
- GC50572 BC-LI-0186
- GC41063 JWH 210 5-ethylnaphthyl isomer
- GC19316 S1p receptor agonist 1
- GC16395 Carteolol HCl
- GC16726 BI-7273
- GC15733 PF-04217903 methanesulfonate
- GC18736 JWH 071
- GN10614 Ginsenoside Rg2
- GC45837 C24 (2'(S)-hydroxy) dihydro Ceramide (d18:0/24:0)
- GN10725 Kirenol
- GC37836 Tubulysin B
- GC12939 Fosmidomycin (sodium salt)
- GC44639 phytanoyl-Coenzyme A (triethylammonium salt)
- GC13856 Dalcetrapib (JTT-705, RO4607381)
- GC16068 A 841720
- GC17728 Cefoselis
レビュー
Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *